{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:18:58Z","timestamp":1783052338922,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1006\/bcmd.2000.0328","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T10:51:07Z","timestamp":1032173467000},"page":"453-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Reduction of the Clinical Severity of Sickle Cell\/\u03b2-Thalassemia with Hydroxyurea: The Experience of a Single Center in Greece"],"prefix":"10.1006","volume":"26","author":[{"given":"Dimitris","family":"Loukopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersi","family":"Voskaridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Kalotychou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Schina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aphrodite","family":"Loutradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Theodoropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/bcmd.2000.0328_RF1","series-title":"Hemoglobin Switching","first-page":"365","article-title":"Clinical trials with hydroxyurea and recombinant erythropoietin","author":"Loukopoulos","year":"1994"},{"key":"10.1006\/bcmd.2000.0328_RF2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.1995.tb08352.x","article-title":"Clinical and laboratory effects of long term administration of hydroxyurea to patients with sickle cell\/beta-thalassemia","volume":"89","author":"Voskaridou","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1006\/bcmd.2000.0328_RF3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/bcmd.2000.0328_RF4","series-title":"Hemoglobin Variants in Human Populations","first-page":"165","article-title":"Hemoglobin variants and thalassemia in Greece","author":"Loukopoulos","year":"1986"},{"key":"10.1006\/bcmd.2000.0328_RF5","first-page":"668","article-title":"Determination of density distribution of red cell populations","volume":"64","author":"Danon","year":"1964","journal-title":"J. Clin. Lab. Med."},{"key":"10.1006\/bcmd.2000.0328_RF6","first-page":"59","article-title":"\u03b2-Thalassemia mutations and the underlying \u03b2 gene cluster haplotypes in the Greek population","volume":"6","author":"Kollia","year":"1992","journal-title":"Gene Geogr."},{"key":"10.1006\/bcmd.2000.0328_RF7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM199004123221504","article-title":"Hematologic responses of sickle cell patients treated with hydroxyurea","volume":"322","author":"Rodgers","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/bcmd.2000.0328_RF8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/03630269109027893","article-title":"The origin of the sickle cell mutation in Greece: Evidence from beta S globin gene cluster polymorphisms","volume":"15","author":"Boussiou","year":"1991","journal-title":"Hemoglobin"},{"key":"10.1006\/bcmd.2000.0328_RF9","article-title":"Administration of hydroxyurea in patients with sickle cell disease induces an inappropriately high secretion of erythropoietin","author":"Papassotiriou","year":"2000","journal-title":"Hematol. J."},{"key":"10.1006\/bcmd.2000.0328_RF10","first-page":"411","article-title":"The \u03b2-thalassemias","volume":"3","author":"Fessas","year":"1974","journal-title":"Clin. Haematol."},{"key":"10.1006\/bcmd.2000.0328_RF11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1056\/NEJM198801143180207","article-title":"Levels of fetal hemoglobin necessary for treatment of sickle cell disease","volume":"318","author":"Noguchi","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/bcmd.2000.0328_RF12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.6200940","article-title":"Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing cell differentiation kinetics","volume":"224","author":"Papayannopoulou","year":"1984","journal-title":"Science"},{"key":"10.1006\/bcmd.2000.0328_RF13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI113437","article-title":"Mechanism of HbF stimulation by S-stage compounds. In vitro studies with bone marrow cells exposed to 5-azacytidine, Ara-C or hydroxyurea","volume":"81","author":"Galanello","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1006\/bcmd.2000.0328_RF14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1006\/bcmd.2000.0328_RF15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1056\/NEJM198512193132503","article-title":"Stimulation of F-cell production in patients with sickle-cell anemia treated cytarabine or hydroxyurea","volume":"313","author":"Veith","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/bcmd.2000.0328_RF16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood.V67.3.735.735","article-title":"Hydroxyurea induction of hemoglobin F production in sickle cell disease: Relationship between cytotoxicity and F cell production","volume":"67","author":"Dover","year":"1986","journal-title":"Blood"},{"key":"10.1006\/bcmd.2000.0328_RF17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1365-2141.1997.d01-2094.x","article-title":"The relative importance of the X-linked FCP locus and beta-globin haplotypes in determining haemoglobin F levels: A study of SS patients homozygous for beta S haplotypes","volume":"96","author":"Chang","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1006\/bcmd.2000.0328_RF18","series-title":"Hematology Trends \u201893. Educational Programme of 12th Meeting of the ISH\/EAD","first-page":"144","article-title":"Evolving therapies in globin gene disorders","author":"Blau","year":"1993"},{"key":"10.1006\/bcmd.2000.0328_RF19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.1999.01339.x","article-title":"Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea","volume":"105","author":"Ballas","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1006\/bcmd.2000.0328_RF20","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood.V89.7.2554","article-title":"Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea","volume":"89","author":"Styles","year":"1997","journal-title":"Blood"},{"key":"10.1006\/bcmd.2000.0328_RF21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005792-199611000-00002","article-title":"Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive \u201cswitching\u201d agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"75","author":"Charache","year":"1996","journal-title":"Medicine"},{"key":"10.1006\/bcmd.2000.0328_RF22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.1999.01565.x","article-title":"Management of sickle cell disease: Recent advances and controversies. Review","volume":"107","author":"Castro","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1006\/bcmd.2000.0328_RF23","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/bcmd.2000.0328_RF24","first-page":"17","article-title":"From efficacy to safety: A Polycythemia Vera Study group report in patients with polycythemia vera","volume":"34","author":"Fruchtman","year":"1997","journal-title":"Semin. Hematol."},{"key":"10.1006\/bcmd.2000.0328_RF25","first-page":"755","article-title":"Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea","volume":"84","author":"Cacciola","year":"1999","journal-title":"Haematologica"},{"key":"10.1006\/bcmd.2000.0328_RF26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s002770050536","article-title":"Treatment of essential thrombocythemia with special emphasis on leukemogenic risk","volume":"78","author":"Finazzi","year":"1999","journal-title":"Ann. Hematol."},{"key":"10.1006\/bcmd.2000.0328_RF27","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood"},{"key":"10.1006\/bcmd.2000.0328_RF28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/adc.81.5.437","article-title":"Preliminary report of a toxicity study of hydroxyurea in sickle cell disease","volume":"81","author":"de Montalembert","year":"1999","journal-title":"Arch. Dis. Child."},{"key":"10.1006\/bcmd.2000.0328_RF29","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I\/II trial. Pediatric Hydroxyurea Group","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"key":"10.1006\/bcmd.2000.0328_RF30","article-title":"Leukemogenesis of hydroxyurea in the treatment of sickle cell anemia. American Society of Hematology 41st Annual Meeting","volume":"94","author":"Rauch","year":"1999","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979600903280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979600903280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:17:55Z","timestamp":1761049075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979600903280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S1079979600903280"],"URL":"https:\/\/doi.org\/10.1006\/bcmd.2000.0328","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of the Clinical Severity of Sickle Cell\/\u03b2-Thalassemia with Hydroxyurea: The Experience of a Single Center in Greece","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/bcmd.2000.0328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}